Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

50 Downloads (Pure)

Original language	English
Pages (from-to)	313-317
Number of pages	5
Journal	Neuropsychiatric Disease and Treatment
Volume	7
DOIs	https://doi.org/10.2147/NDT.S19239
Publication status	Published - 2011

Research programs

@article{6c025401dcbb43c79ebbe63f3c725ef7,

title = "Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands",

author = "B Hoogveldt and Hans Severens and K Maman and C Guillaume",

year = "2011",

doi = "10.2147/NDT.S19239",

language = "English",

volume = "7",

pages = "313--317",

journal = "Neuropsychiatric Disease and Treatment",

issn = "1178-2021",

publisher = "Dove Medical Press Ltd",

}

TY - JOUR

T1 - Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands

AU - Hoogveldt, B

AU - Severens, Hans

AU - Maman, K

AU - Guillaume, C

PY - 2011

Y1 - 2011

U2 - 10.2147/NDT.S19239

DO - 10.2147/NDT.S19239

M3 - Article

SN - 1178-2021

VL - 7

SP - 313

EP - 317

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

ER -